| Literature DB >> 9728556 |
S J Gao1, M Alsina, J H Deng, C R Harrison, E A Montalvo, C T Leach, G D Roodman, H B Jenson.
Abstract
Kaposi's sarcoma-associated herpesvirus (KSHV) serologic assays were used to detect specific antibodies to KSHV lytic and latent antigens in 27 patients with multiple myeloma, 27 control patients with other cancers, and 50 random blood donors. Antibodies to KSHV recombinant minor capsid antigen orf65 were found in 81% of patients with multiple myeloma, 22% of control patients with other cancers, and 6% of the blood donors. Antibodies to KSHV latent nuclear antigens were found in 52% of patients with multiple myeloma, 26% of control patients with other cancers, and 2% of the blood donors. All of the 11 patients with progressive multiple myeloma were KSHV-seropositive. Antibodies to Epstein-Barr virus nuclear antigen 1 were present in 89% of patients with multiple myeloma, 93% of control patients with other cancers, and 88% of the blood donors. These data support the possible association of KSHV infection with multiple myeloma, particularly with progressive disease.Entities:
Mesh：
Substances：
Year: 1998 PMID： 9728556 DOI： 10.1086/515340
Source DB: PubMed Journal: J Infect Dis ISSN： 0022-1899 Impact factor: 5.226